Australia Vitamin B12 Market Size & Outlook, 2026-2034
Last Updated : 16 June, 2026 |
Study Period : 2022-2034 |
Format : PDF, Excel |
Author : Hannah Blake
Australia Vitamin B12 Market Insights
- Based on Deep Market Insights findings, the Australia Vitamin B12 Market reached USD 1.87 Million in 2025 and is estimated to attain USD 3.3 Million by 2034.
- From 2026 to 2034, the Australia market is expected to grow at a steady CAGR of 6.59%.
- Within the Form category, Cyanocobalamin dominated in 2025 in terms of market size contribution.
- Over the forecast period, Hydroxocobalamin is forecasted to deliver the fastest growth, positioning it as the most lucrative Form segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, Australia accounted for 0.81% of the global Vitamin B12 Market size.
- By 2034, United States is expected to lead the global Vitamin B12 Market in terms of market size.
- Within Asia Pacific, China is projected to dominate the regional Vitamin B12 Market size by 2034.
- Korea is identified as the fastest-growing market in Asia Pacific, anticipated to reach USD 4.71 Million by 2034.
Australia Vitamin B12 Market Form 2026-2034 (USD Million)
| Form | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cyanocobalamin | XX.x | XX.x | XX.x | 0.88 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Methylcobalamin | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Hydroxocobalamin | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 1.87 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Australia Vitamin B12 Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharma | XX.x | XX.x | XX.x | 0.85 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Supplements | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Fortified food | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 1.87 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Australia Vitamin B12 Market Route 2026-2034 (USD Million)
| Route | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | XX.x | XX.x | XX.x | 0.84 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Injectable | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Sublingual | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | 1.87 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 1.87 Million |
| Market Size In 2034 | USD 3.3 Million |
| Largest segment | Cyanocobalamin |
| Units | Revenue in USD Million |
| CAGR | 6.59% (2026-2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |